Opiant Pharmaceuticals Inc

NASDAQ:OPNT 4:00:00 PM EDT

20.20

+0.10 (+0.50%)

4:00:05 PM EDT: $20.20 0.00 (0.00%)

Market Cap (Intraday)	104.91M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$1.1 Million
Adjusted EPS	-$2.04

See more estimates

10-Day MA	$20.23
50-Day MA	$20.23
200-Day MA	$14.47

See more pivots

Opiant Pharmaceuticals Inc Stock, NASDAQ:OPNT

233 Wilshire Boulevard, Suite 400, Santa Monica, California 90401

United States of America

Phone: +1.310.598.5410

Number of Employees: 37

http://www.opiant.com

Description

Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Santa Monica, CA.